Profil
Anne-Kirsti Aksnes worked as Director-Clinical Research at GE Healthcare AS.
Dr. Aksnes was Vice President-Clinical Development at Algeta ASA. Dr. Aksnes served as Chief Clinical Officer at Oncoinvent ASA (Old) from 2021 to 2026.
Dr. Aksnes was Vice President-Clinical Research at Bayer AS.
Dr. Aksnes was Vice President-Clinical Development at Circio Holding ASA. Dr. Aksnes earned a doctorate from Karolinska Institutet.
Anciens postes connus de Anne-Kirsti Aksnes
| Sociétés | Poste | Fin |
|---|---|---|
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Directeur Technique/Scientifique/R&D | 28/01/2026 |
| CIRCIO HOLDING ASA | Directeur Technique/Scientifique/R&D | 31/07/2019 |
| ALGETA ASA | Directeur Technique/Scientifique/R&D | - |
GE Healthcare AS
GE Healthcare AS Medical SpecialtiesHealth Technology Specializes in medical imaging services | Directeur Technique/Scientifique/R&D | - |
Bayer AS
Bayer AS Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
Formation de Anne-Kirsti Aksnes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
GE Healthcare AS
GE Healthcare AS Medical SpecialtiesHealth Technology Specializes in medical imaging services | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Bayer AS
Bayer AS Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Circio Holding ASA
Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
















